Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eva van Ingen"'
Autor:
Eva van Ingen, Pleun A.M. Engbers, Tamar Woudenberg, M. Leontien van der Bent, Hailiang Mei, Johann Wojta, Paul H.A. Quax, A. Yaël Nossent
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 30, Iss , Pp 162-172 (2022)
C/D box small nucleolar RNAs (snoRNAs) of the DLK1-DIO3 locus are associated with vascular remodeling and cardiovascular disease. None of these snoRNAs has any known targets yet except for one, AF357425/SNORD113-6. We previously showed that this snoR
Externí odkaz:
https://doaj.org/article/611b5447849f4d83868b5251b99cc594
Autor:
Veerle Kremer, Diewertje I. Bink, Laura Stanicek, Eva van Ingen, Theresa Gimbel, Sarah Hilderink, Stefan Günther, Anne Yaël Nossent, Reinier A. Boon
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract A large portion of the genome is transcribed into non-coding RNA, which does not encode protein. Many long non-coding RNAs (lncRNAs) have been shown to be involved in important regulatory processes such as genomic imprinting and chromatin mo
Externí odkaz:
https://doaj.org/article/3bc5639ebbcb4d0fa042463c3214f86d
Autor:
Eva van Ingen, Amanda C. Foks, Tamar Woudenberg, M. Leontien van der Bent, Alwin de Jong, Philipp J. Hohensinner, Johann Wojta, Ilze Bot, Paul.H.A. Quax, Anne Yaël Nossent
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 1228-1239 (2021)
We have previously shown that treatment with third-generation antisense oligonucleotides against miR-494-3p (3GA-494) reduces atherosclerotic plaque progression and stabilizes lesions, both in early and established plaques, with reduced macrophage co
Externí odkaz:
https://doaj.org/article/3c732ba897314891bf7651163691b08a
Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia
Autor:
Reginald V.C.T. van der Kwast, Laura Parma, M. Leontien van der Bent, Eva van Ingen, Fabiana Baganha, Hendrika A.B. Peters, Eveline A.C. Goossens, Karin H. Simons, Meindert Palmen, Margreet R. de Vries, Paul H.A. Quax, A. Yaël Nossent
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 21, Iss , Pp 932-953 (2020)
Adenosine-to-inosine (A-to-I) editing in the seed sequence of microRNAs can shift the microRNAs’ targetomes and thus their function. Using public RNA-sequencing data, we identified 35 vasoactive microRNAs that are A-to-I edited. We quantified A-to-
Externí odkaz:
https://doaj.org/article/2209272f4f534aa0b0f07a3770ab3c50
Autor:
Eva van Ingen, Amanda C. Foks, Mara J. Kröner, Johan Kuiper, Paul H.A. Quax, Ilze Bot, Anne Yaël Nossent
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 18, Iss , Pp 638-649 (2019)
We have previously shown that third-generation antisense (3GA) inhibition of 14q32 microRNA (miRNA)-494 reduced early development of atherosclerosis. However, patients at risk of atherosclerotic complications generally present with advanced and unsta
Externí odkaz:
https://doaj.org/article/c0ecfbcecf4a4e57b8835ececd858d65
Autor:
M. Leontien van der Bent, Hailiang Mei, Reinier A. Boon, Daphne A L van den Homberg, Paul H.A. Quax, Johann Wojta, Veerle Kremer, Nikolina Papac-Milicevic, A. Yaël Nossent, Eva van Ingen
Publikováno v:
van Ingen, E, van den Homberg, D A L, van der Bent, M L, Mei, H, Papac-Milicevic, N, Kremer, V, Boon, R A, Quax, P H A, Wojta, J & Nossent, A Y 2022, ' C/D box snoRNA SNORD113-6/AF357425 plays a dual role in integrin signalling and arterial fibroblast function via pre-mRNA processing and 2'O-ribose methylation ', Human Molecular Genetics, vol. 31, no. 7, pp. 1051-1066 . https://doi.org/10.1093/hmg/ddab304
Human Molecular Genetics, 31(7), 1051-1066. OXFORD UNIV PRESS
Human Molecular Genetics, 31(7), 1051-1066. Oxford University Press
Human Molecular Genetics, 31(7), 1051-1066. OXFORD UNIV PRESS
Human Molecular Genetics, 31(7), 1051-1066. Oxford University Press
We have previously shown that C/D box small nucleolar RNAs (snoRNAs) transcribed from the DLK1-DIO3 locus on human chromosome 14 (14q32) are associated with cardiovascular disease. DLK1-DIO3 snoRNAs are ‘orphan snoRNAs’ that have no known targets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b58e08eb44713352dff1899c53be85
https://research.vumc.nl/en/publications/6e40b26c-732c-409a-ae7e-ad9a7fce5582
https://research.vumc.nl/en/publications/6e40b26c-732c-409a-ae7e-ad9a7fce5582
Autor:
Eva, van Ingen, Pleun A M, Engbers, Tamar, Woudenberg, M Leontien, van der Bent, Hailiang, Mei, Johann, Wojta, Paul H A, Quax, A Yaël, Nossent
Publikováno v:
Molecular therapy. Nucleic acids. 30
C/D box small nucleolar RNAs (snoRNAs) of the DLK1-DIO3 locus are associated with vascular remodeling and cardiovascular disease. None of these snoRNAs has any known targets yet except for one, AF357425/SNORD113-6. We previously showed that this snoR
Autor:
Reinier A Boon, Sarah Hilderink, Eva van Ingen, Veerle Kremer, Laura Stanicek, Diewertje I. Bink, Anne Yaël Nossent
A large portion of the genome is transcribed into non-coding RNA, which does not encode protein. Many long non-coding RNAs (lncRNAs) have been shown to be involved in important regulatory processes such as genomic imprinting and chromatin modificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccb9c82bc8f411ed683a170d132aa434
https://doi.org/10.21203/rs.3.rs-800527/v1
https://doi.org/10.21203/rs.3.rs-800527/v1
Autor:
J. Wouter Jukema, Johann Wojta, Kjell Erik Julius Håkansson, Margreet R. de Vries, Reginald V.C.T. van der Kwast, Christoph Kaun, Eveline A. C. Goossens, Philipp J. Hohensinner, Stella Trompet, Jens Kastrup, Stefan Böhringer, Paul H.A. Quax, A. Yaël Nossent, Eva van Ingen, Saskia le Cessie, Rasmus S. Ripa
Publikováno v:
Cardiovascular Research, 115(10), 1519-1532
Aims We have shown that 14q32 microRNAs are highly involved in vascular remodelling and cardiovascular disease. However, the 14q32 locus also encodes 41 ‘orphan’ small nucleolar RNAs (snoRNAs). We aimed to gather evidence for an independent role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbdb192a055bb1bf6b65f937a2c0f981
http://hdl.handle.net/1887/120911
http://hdl.handle.net/1887/120911
Autor:
Joost P.G. Sluijter, Nathan W. Ng, Vera M. Pieters, Melissa J. Hernandez, Monika Dzieciatkowska, Kirk C. Hansen, Emma A. Mol, Roberto Gaetani, Eva van Ingen, Audrey E. Chang, Taylor R. Martin, Karen L. Christman
Publikováno v:
Advanced Therapeutics
In the last decade, the use of microRNA (miRNA) and extracellular vesicle (EV) therapies has emerged as an alternative approach to mitigate the negative effects of several disease pathologies ranging from cancer to tissue and organ regeneration; howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925cd6f6710700e449a91e55671fb1d8
http://hdl.handle.net/11573/1280876
http://hdl.handle.net/11573/1280876